Trials / Completed
CompletedNCT01305070
Standard Balloon Angioplasty Versus Angioplasty With a Paclitaxel-eluting Balloon for Femoral Artery In-stent Restenosis
Femoral Artery In-Stent Restenosis (FAIR) Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 118 (estimated)
- Sponsor
- Medical Care Center Prof. Mathey, Prof. Schofer, Ltd. · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of recurrent-restenosis rates 6 months after angioplasty of in-stent restenoses or in-stent reocclusions in the superficial femoral artery (SFA) using either a standard balloon (Admiral Xtreme, Invatec) or a paclitaxel-eluting balloon (In.Pact™ Admiral, Invatec).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Admiral Xtreme | For balloon angioplasty of in-stent restenosis in the superficial femoral artery |
| DEVICE | In.Pact Admiral | For balloon angioplasty of in-stent restenosis in the superficial femoral artery |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2012-12-01
- Completion
- 2013-06-01
- First posted
- 2011-02-28
- Last updated
- 2015-02-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01305070. Inclusion in this directory is not an endorsement.